1. Home
  2. HCM vs BCRX Comparison

HCM vs BCRX Comparison

Compare HCM & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

N/A

Current Price

$13.45

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

N/A

Current Price

$7.31

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HCM
BCRX
Founded
2000
1986
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
HCM
BCRX
Price
$13.45
$7.31
Analyst Decision
Strong Buy
Buy
Analyst Count
11
11
Target Price
★ $21.14
$20.45
AVG Volume (30 Days)
37.1K
★ 4.5M
Earning Date
07-30-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 381.40
EPS
★ N/A
N/A
Revenue
N/A
★ $25,186,000.00
Revenue This Year
$14.11
N/A
Revenue Next Year
$11.97
$3.71
P/E Ratio
$5.49
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$9.77
$6.23
52 Week High
$16.33
$11.22

Technical Indicators

Market Signals
Indicator
HCM
BCRX
Relative Strength Index (RSI) 40.65 37.29
Support Level $13.00 N/A
Resistance Level $14.74 $8.83
Average True Range (ATR) 0.38 0.37
MACD -0.10 -0.04
Stochastic Oscillator 17.90 5.42

Price Performance

Historical Comparison
HCM
BCRX

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: